Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Inflection Point Acquisition Corp. VI, a special purpose acquisition company (SPAC), announced the pricing of its IPO, offering 22 million units at $10 each, expected to raise $220 million. The units will trade on Nasdaq under ticker IPFXU, with separate trading expected for shares and warrants under IPFX and IPFXW respectively. The company aims to…
Hydrofarm Holdings Group, Inc. announced its fourth quarter and full year 2025 financial results showing a 32.7% reduction in net sales for Q4 compared to the prior year, driven by industry oversupply and price decreases. Despite improvements in gross profit margins and reduced operating expenses due to restructuring efforts, the company reported a…
Glucotrack, Inc. announced significant progress towards filing an Investigational Device Exemption (IDE) with the U.S. FDA in Q2 2026 to initiate a U.S. clinical trial for its implantable continuous blood glucose monitoring system. Following successful first-in-human trials in Brazil and a follow-up study in Australia, the company completed key tri…
Coeur Mining (CDE) recently closed its New Gold acquisition and announced 2026 guidance of 680k-815k gold ounces, a $750M share repurchase and a new dividend. Balance-sheet strength (cash ~$1.41B, FCF ~$665.7M) and 4.4M oz of proven and probable gold reserves ($22.1B implied valuation at $5,020/oz) are underappreciated by the market. Technicals sho…
JBS trades at roughly $16.76 with a market cap near $17.8B, a PE near 8.8 and 52-week range $12.37–$18.02. Rising beef prices, successful note exchange activity and constructive technicals create an attractive swing trade: entry $16.76, stop $15.00, target $19.00 over ~45 trading days.
Senti Biosciences announced its fourth quarter and full year 2025 financial results, marking significant progress in its clinical pipeline, particularly with SENTI-202 for relapsed/refractory acute myeloid leukemia (AML). The company reported positive preliminary Phase 1 clinical data, received FDA Regenerative Medicine Advanced Therapy designation…
IREN is building GPU-ready, grid-connected data center capacity in renewable-rich regions and has already converted that advantage into big contracts and rapid revenue growth. The stock has pulled back after a capital raise and worries about utilization, creating a trade opportunity for disciplined, event-driven traders who believe IREN can scale i…
Marcopolo is leaning on international markets to make up for a softer outlook at home in 2026, boosting exports across Latin America and preparing a push into European markets. International operations accounted for nearly half of the company's net revenue in 2025, and executives say they are seeing momentum in multiple neighboring countries while …
Norwegian Cruise Line Holdings Ltd. announced the appointment of John W. Chidsey as President and CEO, effective February 2026, accompanied by a new employment agreement and a $48 million restricted share unit award designed to incentivize long-term shareholder value creation over four years. The equity award includes performance-based and time-ves…
U.S. ambassador to the European Union Andrew Puzder told CNBC that the EU risks excluding itself from the artificial intelligence economy if it imposes heavy regulation and fines on American technology companies. Puzder said participation in AI requires data centers, data flows and access to U.S. AI hardware, and cautioned that shifting regulatory …
Trade ministers gathered in Yaounde, Cameroon, remain committed to negotiating World Trade Organization reforms, but deep divisions persist, notably between the United States and India. Key sticking points include whether to adopt a detailed reform workplan, extension of an e-commerce moratorium, the inclusion of an Investment Facilitation for Deve…
Goldman Sachs said in a Friday note that a cooling of geopolitical tensions could allow global equities to resume recent outperformance and put downward pressure on the U.S. dollar. The bank argued markets are currently balancing high inflation against weak growth while pricing in risks from the Iran conflict and a possible sustained energy shock. …
Profound Medical Corp. announced that Texas Prostate, led by Dr. James Cochran, has reached the milestone of performing 100 TULSA Procedures using Profound's TULSA-PRO system at Dallas Medical Center. The collaboration has increased procedure volume by 500% since transitioning to a Medicare payment model, accelerating adoption of this innovative, M…
Goldman Sachs downgraded Beiersdorf (ETR:BEIG) from Buy to Neutral following FY25 results, trimming earnings forecasts and reducing its FY26 revenue estimate to €9.86 billion. The bank flagged decelerating NIVEA sales, weakness at La Prairie and margin headwinds driven by raw material costs, foreign exchange and limited operating leverage. It also …
Clearmind Medicine Inc., a Nasdaq-listed clinical-stage biotech company, announced the filing of a patent application in India for next-generation psychedelic compounds aimed at treating mental health disorders and addiction. This move expands the company's global intellectual property portfolio and builds on its licensing agreement with Yissum Res…
Social media and prediction markets have lit up around the prospect of a SpaceX public offering, with users placing millions of dollars on the likely ticker, listing venue and valuation. Market wagers, shifting odds for a single-letter ticker, and discussions about an unusually large retail allocation underscore the unusual investor focus on the pr…
Streamex Corp. clarifies and disproves misleading third-party reports about the expiration of lock-up agreements related to its January 2026 financing. The company confirms that the previous lock-ups of certain shares held by co-founders Henry McPhie and Morgan Lekstrom were shorter than reported and that newly agreed voluntary one-year lock-ups ha…
Bank of America views the recent pullback in semiconductor memory stocks — triggered by headlines around Google's TurboQuant compression technology — as an overreaction. The bank's analysts say AI capital expenditure remains the primary signal of memory demand and point to rising memory on next-generation chips, increased cloud capex guidance and h…
Early economic effects from the Iran war are surfacing in Britain, with surging gas prices and downgrades to growth and inflation forecasts constraining both monetary and fiscal policymakers. The combination of higher energy costs, falling consumer confidence, and limited fiscal headroom raises difficult trade-offs for the Bank of England and the g…
Benchmark U.S. Treasury yields rose to their strongest levels since July as oil prices resumed an upward trajectory and investors processed news that the White House extended its deadline for possible strikes on Iranian energy infrastructure. The advance in yields came despite the announced extension and against a backdrop of tightened expectations…
Jefferies recommends selective purchases in the paper and packaging sector after a broad sell-off tied to the Iran war and related energy-market disruptions. The group has fallen about 14% since the conflict began. The firm outlines how Amcor, Crown Holdings and Ball Corporation are positioned to manage higher input costs through scale, pass-throug…
Goldman Sachs adjusted its coverage of several Italian banks, upgrading Intesa Sanpaolo to buy with a €6.9 price target and 36% upside, downgrading Banco BPM to neutral, and initiating coverage of Banca Monte dei Paschi di Siena and BPER Banca at buy and neutral respectively. The moves rest on changes to profit and capital forecasts, valuation comp…
Rocket Pharmaceuticals saw its stock climb after the U.S. Food and Drug Administration gave accelerated approval to KRESLADI, an autologous hematopoietic stem cell-based gene therapy for pediatric patients with severe leukocyte adhesion deficiency-I (LAD-I) who lack an HLA-matched sibling donor for allogeneic transplant. The approval is based on bi…
The Bank of Spain estimates first-quarter GDP rose between 0.5% and 0.6%, a deceleration from 0.8% in Q4. It raised its baseline growth forecast for 2026 to 2.3% from 2.2%, factoring in the economic effects of the war in Iran. The central bank also adjusted inflation and public finance projections while noting that energy price and external market …
Sportradar Group AG, a leading global sports technology company, announced the filing of its annual report on Form 20-F for the fiscal year ended December 31, 2025, with the SEC. The report is available to investors via the company’s website and SEC filings. Sportradar provides technology and services to sports federations, media, and betting opera…
